Wei Tan - Department of Biostatistics, Roswell Park Cancer Institute

基本信息

浏览量：86

职业迁徙

个人简介

Cancer research

研究兴趣

论文共 142 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT053: Exploration of Potential Biomarkers Correlated with Efficacy of Ociperlimab (Anti-Tigit) Plus Tislelizumab (Anti-Pd-1) in 1L PD-L1+ Non-Small Cell Lung Cancer (NSCLC)

Se Hyun Kim, Jiayuan Zhang,Wei Tan, Han Yan, Tian, Hao Zheng, Ziqi Zhou, Ruihua Wang,Yun Zhang,Zhirong Shen,Hye Ryun Kim,Diansheng Zhong,Shun Lu

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

胃困难部位间质瘤内镜与腹腔镜治疗临床疗效比较

赵敏,谭韡,罗和生

Chinese Journal of Gastroenterology and Hepatologyno. 5 (2023)

引用0浏览0引用

AdvanTIG-105: A Phase 1b Dose-Expansion Study of Ociperlimab (OCI) + Tislelizumab (TIS) with Chemotherapy (chemo) in Patients (pts) with Stage IV Gastric/gastroesophageal Adenocarcinoma (GC/GEJC)

Se Hyun Kim,Gyeong-Won Lee,Byoung Yong Shim, David R. Spigel,Her-Shyong Shiah,Sophia Frentzas,Harry H. Yoon,Feng Wang,Meili Sun,Timothy Dudley Clay,Hao Zheng,Wei Tan, Ziqi Zhou,Ruihua Wang,Yi Ba

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

肠道微生物相关的结肠动力学机制研究进展

夏源,谭韡,罗和生

胃肠病学和肝病学杂志（2023）

引用0浏览0引用

AdvanTIG-105: a Phase I Dose Escalation Study of the Anti-Tigit Monoclonal Antibody Ociperlimab in Combination with Tislelizumab in Patients with Advanced Solid Tumors

Sophia Frentzas,Steven Kao,Rang Gao, Hao Zheng,Ahsan Rizwan,Nageshwar Budha, Luz de la Hoz Pedroza,Wei Tan,Tarek Meniawy

Journal for immunotherapy of cancerno. 10 (2023): e005829-e005829

引用0浏览0WOS引用

Prediction of intratumoral TIGIT receptor occupancy after the treatment with anti-TIGIT antibodies

Dmitry Shchelokov,Oleg Demin,Oleg Demin,Ahsan Rizwan, Yun Zhang,Wei Tan,Srikumar Sahasranaman,Nageshwar Budha

CANCER RESEARCHno. 12 (2022)

引用0浏览0引用

768 Peripheral Pharmacodynamic (PD) Effects of Ociperlimab (OCI) in Combination with Tislelizumab (TIS) in Patients with Advanced Solid Tumors: AdvanTIG-105 Phase 1 Dose-Escalation Study

Wei Tan,Yang Shi, Han Yan,Zhirong Shen,Nageshwar Budha,Ahsan Rizwan,Ruiqi Huang, Hao Zheng,Rang Gao,Sophia Frentzas,Steven Kao,Tarek Meniawy,Yun Zhang

Regular and Young Investigator Award Abstracts (2022)

引用0浏览0引用

Abstract 5421: Prediction of Intratumoral TIGIT Receptor Occupancy after the Treatment with Anti-Tigit Antibodies

Dmitry Shchelokov,Oleg Demin,Ahsan Rizwan, Yun Zhang,Wei Tan,Srikumar Sahasranaman,Nageshwar Budha

Cancer researchno. 12_Supplement (2022): 5421-5421

引用0浏览0引用

巴林特小组活动在内科住院医师规范化培训中的应用

谭韡,肖文静, 吕小斌, 周巍

中华医学教育探索杂志（2022）

引用0浏览0引用

Phase Ia study of CBP-1008, a bi-specific ligand drug conjugate targeting FR alpha and TRPV6, in patients with advanced solid tumors

Jifang Gong,Xichun Hu,Jian Zhang,Yiqun Du,Robert Huang,Yan Teng,Wei Tan,Lin Shen

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn